The Recall Registry
Recall data checked 5 hours ago

Home Prescription medicine Breckenridge Pharmaceutical, Inc — Duloxetine…

Food & drug recall · FDAOctober 10, 2024Serious

Breckenridge Pharmaceutical, Inc — Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Distributed by: BPI, NDC 51991-746-05.

Do not stop taking this without speaking to your pharmacist or doctor.

Why this is on The Recall Registry: This is a consumable product recalled for what is inside it. It was found to contain a drug or chemical that is not on the label. That is different from an allergen or a contamination scare: anyone taking it has been taking a substance nobody prescribed, in an unknown dose, and it can interact with medication they are already on. Follow the agency notice rather than judging it by how the product looks.

What’s wrong

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

The Recall Registry rates this seriousFDA Class II: temporary or medically reversible health harm.

What to do

Check the lot numbers below against what you have. Do not stop taking a prescription medicine because of a recall without speaking to your pharmacist or doctor first — for many medicines stopping is more harmful than continuing, and they can tell you whether yours is affected and what to do about it.

Who to contact: Recalling firm: Breckenridge Pharmaceutical, Inc

The product

Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Distributed by: BPI, NDC 51991-746-05.

Details

Units affected
7,107 bottles
Recall date
October 10, 2024
Brand
Breckenridge Pharmaceutical, Inc
Model, lot or SKU numbers
Lot #: 220128, Exp. Date 12/2024
Where it was distributed

Product was distributed nationwide within the United States

The official notice

This recall was issued by the U.S. Food and Drug Administration. The Recall Registry summarises it — always confirm the details at the source.

Their exact wording: Breckenridge Pharmaceutical, Inc — Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Distributed by: BPI, NDC 51991-746-05.

Read it on FDA

Worried about the other things in your house? You can write down what you have and be told if one is recalled — or, if you sell second-hand, check your whole stock at once.

Filed under: Prescription medicine

Other prescription medicine recalls